Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Repurposing of FDA approved an...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Repurposing of FDA approved antibiotics as antimalarial agents: A network pharmacology based in silico approach

Repurposing of FDA approved antibiotics as antimalarial agents: A network pharmacology based in silico approach

Bibliographic Details
Main Authors: B. Gogoi, N. Gogoi, P. Chowdhury, D. Chetia
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220310389
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S1201971220310389

Similar Items

  • In Silico and In Vitro Potential of FDA-Approved Drugs for Antimalarial Drug Repurposing against Plasmodium Serine Hydroxymethyltransferases
    by: Pitchayathida Mee-udorn, et al.
    Published: (2023-09-01)
  • In silico repurposing of FDA-approved drugs as multi-target inhibitors of glioblastoma
    by: Ridwan Abiodun Salaam, et al.
    Published: (2025-03-01)
  • In vitro antimalarial activity evaluation of two ethnomedicinal plants against chloroquine sensitive and resistant strains of Plasmodium falciparum
    by: Neelutpal Gogoi, et al.
    Published: (2021-05-01)
  • Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An in silico study
    by: Alfred Olaoluwa Akinlalu, et al.
    Published: (2021-09-01)
  • In Silico Drug Repurposing Approach: Investigation of <i>Mycobacterium tuberculosis</i> FadD32 Targeted by FDA-Approved Drugs
    by: Nolwazi Thobeka Portia Ngidi, et al.
    Published: (2022-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs